Geburtshilfe und Frauenheilkunde

Journal Abbreviation: GEBURTSH FRAUENHEILK
ISSN: 0016-5751
Publisher: Georg Thieme Verlag

Publications (257)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

New Screening Proposals: the Federal Joint Commission Defines the Parameters for Cervical Cancer Screening from 2018 Statement of the Gynecology Oncology Working Group (AGO) (2016) Hillemanns P, Mallmann P, Beckmann M Journal article Help Shape Training (2016) Gabriel L, Lermann J, Schott S, Puppe J Journal article Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015) (2016) Tempfer C, Horn LC, Ackermann S, Beckmann M, Dittrich R, Einenkel J, Guenthert A, et al. Journal article Health-related Quality of Life in Metastatic and Adjuvant Breast Cancer Patients (2016) Wallwiener M, Simoes E, Sokolov AN, Brucker SY, Fasching P, Graf J Journal article Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015 (2016) Schnuerch HG, Ackermann S, Alt CD, Barinoff J, Boeing C, Dannecker C, Gieseking F, et al. Journal article Editor's Comment on the Review of the German IVF Register and the Subsequent Discussion (2016) Beckmann M Journal article, Note A Review of Integrative Medicine in Gynaecological Oncology (2016) Kalder M, Mueller T, Fischer D, Mueller A, Bader W, Beckmann M, Brucker C, et al. Journal article, Review article Considerations on the Improved Integration of Medical Guidelines into Routine Clinical Practice - a Review and Concept Proposal (2016) Beckmann M, Schlieter H, Richter P, Wesselmann S Journal article Senology in Gynaecology Specialist Training: a Baseline Survey from 2014 (2016) Puppe J, Dieterich M, Bayer C, Neiman J, Mendes MDS, Gaß P, Lermann J, Schott S Journal article Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial (2016) Schroeder L, Rack B, Sommer H, Koch JG, Weissenbacher T, Janni W, Schneeweiss A, et al. Journal article